methylbenzethonium chloride has been researched along with Leishmaniasis, American in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (64.29) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Kishk, I; Berkovitch, M; El-On, Y; Livneh, A; Youngster, I | 1 |
| Bleys, J; Chung, HJ; Ghohestani, RF; Kim, DH | 1 |
| Armijos, RX; Calvopiña, M; Mancheno, M; Rodriguez, R; Weigel, MM | 1 |
| Bazarsky, E; El-On, J; Sneir, R | 1 |
| Berman, J; Grogl, M; Hernandez, N; Mejia, H; Soto, J | 1 |
| Lemke, KR; Schallreuter, KU | 1 |
| Berman, J; Fuya, P; Herrera, R; Soto, J | 1 |
| Amichai, B; Grunwald, MH; Trau, H | 1 |
| Berman, JD; Ellis, WY; Grogl, M; Schuster, BG | 1 |
| Krause, G; Kroeger, A | 1 |
| Arana, BA; Kroeger, A; Mendoza, CE; Rizzo, NR | 1 |
| el-On, J; Elias, E; Sneier, R | 1 |
| el-On, J; Grunwald, MH; Halevy, S; Weinrauch, L | 1 |
| el-On, J; Schnur, LF; Sulitzeanu, A | 1 |
1 review(s) available for methylbenzethonium chloride and Leishmaniasis, American
| Article | Year |
|---|---|
Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials.
Topics: Antiprotozoal Agents; Benzethonium; Humans; Leishmaniasis, Cutaneous; Paromomycin; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
5 trial(s) available for methylbenzethonium chloride and Leishmaniasis, American
| Article | Year |
|---|---|
Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
Topics: Administration, Topical; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzethonium; Double-Blind Method; Humans; Injections, Intramuscular; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Treatment Failure; Urea | 2004 |
Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
Topics: Administration, Topical; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzethonium; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intramuscular; Injections, Intravenous; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Paromomycin | 1995 |
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
Topics: Antiprotozoal Agents; Benzethonium; Double-Blind Method; Drug Therapy, Combination; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin | 1998 |
Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.
Topics: Adolescent; Adult; Antiprotozoal Agents; Benzethonium; Child; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Middle Aged; Ointments; Paromomycin | 2001 |
Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.
Topics: Administration, Cutaneous; Adolescent; Adult; Animals; Anti-Infective Agents, Local; Benzethonium; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infant; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Middle Aged; Ointments; Paromomycin | 1992 |
8 other study(ies) available for methylbenzethonium chloride and Leishmaniasis, American
| Article | Year |
|---|---|
The lack of effectiveness of hyperbaric oxygenation as a treatment for Leishmania major in a mouse model.
Topics: Animals; Antiprotozoal Agents; Benzethonium; Disease Models, Animal; Drug Therapy, Combination; Hyperbaric Oxygenation; Leishmania major; Leishmaniasis, Cutaneous; Mice, Inbred BALB C; Paromomycin; Treatment Outcome | 2015 |
Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antiprotozoal Agents; Benzethonium; Drug Therapy, Combination; Imiquimod; Leishmania major; Leishmaniasis, Cutaneous; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Ointments; Paromomycin; Rabbits | 2007 |
[Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].
Topics: Administration, Topical; Adult; Antiprotozoal Agents; Benzethonium; Drug Administration Schedule; Drug Therapy, Combination; Facial Dermatoses; Humans; Leishmaniasis, Cutaneous; Male; Paromomycin | 1994 |
Cutaneous leishmaniasis on an unusual site--the glans penis.
Topics: Adult; Anti-Bacterial Agents; Benzethonium; Humans; Leishmaniasis, Cutaneous; Male; Ointments; Paromomycin; Penile Diseases | 1998 |
Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
Topics: Administration, Topical; Animals; Antiprotozoal Agents; Benzethonium; Cricetinae; Drug Therapy, Combination; Gentamicins; Leishmania; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Paromomycin; Treatment Outcome; Urea | 1999 |
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study.
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antiprotozoal Agents; Benzethonium; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Infusions, Parenteral; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Treatment Failure; Wound Healing | 1999 |
Leishmania major: bacterial contamination of cutaneous lesions in experimental animals.
Topics: Animals; Anti-Infective Agents, Local; Bacterial Infections; Benzethonium; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Leishmaniasis, Cutaneous; Macrophages; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutrophils; Paromomycin; Time Factors; Treatment Outcome | 1992 |
Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Benzethonium; Drug Resistance; Drug Therapy, Combination; Leishmania tropica; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Paromomycin; Time Factors | 1991 |